These final results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the concept of targeting ACKR3 as a novel way to modulate the opioid technique, which could open new therapeutic avenues for opioid-relevant Conditions. For those who have questions https://carlg384bsj0.wonderkingwiki.com/user